Organisation paid for research Program year 2022 Source: CMS Open Payments

Vilo Research Group

Neither a doctor nor a teaching hospital

Research payments

$69,653

36 payments

Through program year 2022, Vilo Research Group is reported as receiving $69,653 in research payments, across 36 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$5,026	2
2021	Research	$3,729	3
2020	Research	$21,910	8
2019	Research	$38,989	23

Breakdown

Who paid Research payments · program years 2019–2022

Allergan Inc. $57,794 20 payments
Shionogi Inc $11,859 16 payments

Studies the money was for Research payments · program years 2019–2022

A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double- Dummy, Placebo and Active-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants with Moderately to Severely Active Ulcerative Colitis $14,491 4 payments
Study of S-033188 Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complications CAPSTONE 2 $11,859 16 payments
Clinical Trial LIN-MD-64 Ped FC Trial 6-17 Ph3 $9,844 3 payments
A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-Controlled, Operationally Seamless Phase 2b/3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab in Participants with moderately to Severely Active Croh $8,898 3 payments
A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-Controlled, Operationally Seamless Phase 2b3, Parallel-group Study to Assess the Efficacy and Safety of Brazikumab in Participants with moderately to Severely Active Croh $8,604 2 payments
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) $7,888 4 payments
Clinical Trial (LIN-MD-64: Ped FC Trial 6-17 Ph3) $6,989 3 payments
Chronic Idiopathic Constipation (Cic),Irritable Bowel Syndrome With Constipation (Ibs-C) $1,080 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.